II. Indications
- Migraine Headache refractory to home care (6-72 hours)
- Headache Red Flag (e.g. Thunderclap Headache)
III. Epidemiology
- Migraine Headache is the fourth most common presentation to emergency departments in the United States
IV. Causes
- See Headache Causes
V. History
- See Headache History
VI. Examination
VII. Diagnostics
- See Headache Diagnostic Testing
- See Subarachnoid Hemorrhage for CT Head and Lumbar Puncture protocol
VIII. Precautions
- See Headache Red Flags (e.g. Thunderclap Headache, Fever)
- Do not miss serious Headache Causes (e.g. Subarachnoid Hemorrhage, Meningitis)
- Avoid agents less effective in treating Headache (non-DopamineAntagonist Antiemetics)
- Promethazine (Phenergan) 12.5 mg IV
- Hydroxyzine
- Opioids (e.g. Hydromorphone, Morphine)
- ParenteralLidocaine
- Octreotide
IX. Preparations: DopamineAntagonist Antiemetics
- Precautions
- Administer via Parenteral Route (IV preferred or IM)
- Oral route is unlikely to be effective with these agents due to their high first-pass metabolism
- Extrapyramidal Side Effects (especially Akathisia) occurs in 5-40% of cases when given these Anti-emetics
- Administer these agents slowly (e.g. dilute in saline and run over 20 minutes)
- Lower risk of Extrapyramidal Side Effects (Akathisia) when slowly infused
- Parlak (2007) Postgrad Med 83(984):664-8 +PMID:17916877 [PubMed]
- Diphenhydramine (Benadryl)
- Guidelines no longer recommended prophylactic use to prevent Extrapyramidal Side Effects
- Has not been found effective in reducing Extrapyramidal Side Effects
- Consider administering if Akathisia occurs
- Friedman (2016) Ann Emerg Med 67(1): 32-9 [PubMed]
- Administer these agents slowly (e.g. dilute in saline and run over 20 minutes)
- Administer via Parenteral Route (IV preferred or IM)
-
Prochlorperazine (Compazine) with IV hydration
- Often effective for aborting intractable Headache
- Consider with Diphenhydramine 12.5 to 50 mg IV to reduce risk of Akathisia, Dystonia
- Adults: 10 mg IV
- Child: 0.15 mg/kg IV
-
Metoclopramide (Reglan) 10 mg IV
- Excellent first-line agent for Migraine with Nausea
- Optimal dose appears to be 10 mg IV
- Colman (2004) BMJ 329(7479): 1369-73 [PubMed]
- Friedman (2011) Ann Emerg Med 57(5): 475-82 +PMID:21227540 [PubMed]
-
Droperidol (Inapsine)
- Dose: 1.25 to 5 mg slow IV or IM (typical dose 2.5 mg IV, doses as low as 0.625 may be effective)
- FDA black box warning due to QT Prolongation risk
- EKG monitoring for single or cummulative doses above 1.25 mg
- Olanzapine (Zyprexa) or Haloperidol (Haldol) have been used as alternatives in Migraine Headache
X. Preparations: Serotonin Agonist
- Precautions
- Do not use if Coronary Artery Disease, Cerebrovascular Accident, Uncontrolled Hypertension
- Do not use with MAO Inhibitors, and Exercise caution with other serotonergic agents (e.g. SSRI)
- Triptans have high Incidence of side effects with Emergency Department use (30%)
- Dizziness
- Blurred Vision
- Confusion
- Chest Pain
-
Triptans (preferred)
- Sumatriptan (Imitrex) intranasal, oral or 6 mg subcutaneous
- Zolmitriptan (Zomig) intranasal or oral
-
Dihydroergotamine
Mesylate (DHE, not generally used)
- DHE 0.5 to 1 mg IV every 8 hours up to cummulative maximum of 3 mg
- Migranal 1 spray in each nostril and may repeat once after 15 minutes
- References
XI. Preparations: Analgesic or Anti-inflammatory
-
Ketorolac (Toradol)
- Dose: 30 mg IV (60 mg IM)
- However, one study on general pain management in ED found maximal effect at only 10 mg IV
- Motov (2017) Ann Emerg Med 70(2): 177-84 +PMID: 27993418 [PubMed]
- Dose: 30 mg IV (60 mg IM)
-
Dexamethasone
- Dose: 4 to 10 mg IV or oral
- Doses above 10 mg are unlikely to provide added benefit
- Studies showed benefit at 4 to 8 mg (dose 4 mg may offer adequate benefit and lower risk)
- Hydrocortisone or Methylprednisolone IV could be used as alternative (however Dexamethasone is preferred)
- Onset of activity is delayed at least 6 hours from administration
- May prevent Headache recurrence in following 48-72 hours
- Colman (2008) BMJ 336(7657): 1359-61 +PMID:18541610 [PubMed]
- Friedman (2023) Neurology 101(14): e1448-54 +PMID: 37604662 [PubMed]
- Mirabaha (2017) Adv J Emerg Med 1(1):e6 +PMID: 31172058 [PubMed]
- Singh (2008) Acad Emerg Med 15(12): 1223-33 [PubMed]
- Dose: 4 to 10 mg IV or oral
- Intranasal Lidocaine
- Position patient supine with head hyperextended with tilt to 30 degrees
- Lidocaine 4%, 0.5 ml of solution dripped into nostril on affected side over 30 seconds
- Not recommended in current Migraine Headache guidelines as of 2017
- Magnesium
-
Opioids (avoid if possible)
- Still used in 47% of emergency visits, but not recommended in guidelines
XII. Preparations: Other agents that have been used historically
-
Intravenous Fluids
- Most emergency department Headache protocols use Intravenous Fluid bolus
- However, no benefit found in Headache relief when combined with Metoclopramide
-
Antipsychotics with Analgesic and Antiemetic properties
- Haloperidol (Haldol) 5 mg IV (pre-bolus 500 to 1000 cc of IV fluids)
- Olanzapine (Zyprexa) 5-10 mg ODT or IM once
- Chlorpromazine (Thorazine) 12.5 mg IV q20 min prn x3 (avoid)
- Anticonvulsant - Valproic Acid (Depacon)
- Depacon 300-1000 mg in 100 cc NS IV over 30 minutes
XIII. Preparations: Status Migrainosus (severe refractory Migraine)
- Reconsider Headache Differential Diagnosis
- Experimental (preliminary data only)
- Propofol (sub-Anesthetic dosing)
- Follow same protocols as for Conscious Sedation (but dose is ~25% of those doses)
- Obtain Informed Consent
- Monitoring as with Conscious Sedation
- Observe for 2 hours following administration
- Dosing (listed for completeness, experimental only)
- Adults: 20-30 mg every 5 minutes to effect (average total dose 100 mg)
- Child: 0.5 mg/kg every 5 minutes to effect
- Efficacy
- Highly effective, resolving Headache in most patients within 30 minutes (and remained awake)
- Krusz (2000) Headache 40(3): 224-30 [PubMed]
- Soleimanpour (2012) BMC Neurol 12:114 [PubMed]
- Sheridan (2012) Pediatr Emerg Care 28(12): 1293-6 [PubMed]
- Pietka (2020) Acad Emerg Med 27(2):148-60 [PubMed]
- Follow same protocols as for Conscious Sedation (but dose is ~25% of those doses)
- Propofol (sub-Anesthetic dosing)
- References
- Claudius and Mecklar in Majoewsky (2012) EM:RAP 12(10): 11-12
XIV. Management: Regional Anesthesia
- Greater Occipital Nerve Block
- Sphenopalatine Block
XV. References
- Lin (2017) EM:Rap 17(11): 9-10
- Diamond (1997) Postgrad Med 101(1):169-79 [PubMed]
- Friedman (2017) Ann Emerg Med 69(2): 202-7 [PubMed]
- Kabbouche (2001) Pediatrics 107:e62 [PubMed]
- Kelly (2000) West J Med 173:189-93 [PubMed]
- Newman (1998) Neurol Clin 16(2):285-303 [PubMed]
- Orr (2016) Headache 56(6): 911-40 +PMID:27300483 [PubMed]
- Vinson (2003) Ann Emerg Med 41:90-7 [PubMed]